Mendota Financial Group »

Cytek Biosciences shares owned by Mendota Financial Group

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Mendota Financial Group from 13F filings

Historical chart of Mendota Financial Group investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Mendota Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Mendota Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $73 13 5.62

More positions owned by Mendota Financial Group

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Capital Group International SHS (CGIE)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Loews Corporation (L)
Meta Platforms Cl A (META)
PAR Technology Corporation (PAR)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Mendota Financial Group

Top funds holding Cytek Biosciences

BlackRock
BlackRock
Vanguard Group
Brown Capital Management
Hillhouse Capital Advisors
State Street Corporation
Geode Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Bank of New York Mellon
Connor, Clark & Lunn Investment Management

View all funds holding Cytek Biosciences